The dopamine precursor L-dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex

American Journal of Physiology - Renal Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Quiñones, Henry ^a   Collazo, Roberto ^b   Moe, Orson W ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

Amino acid transport; Proximal tubule; Sodium balance

Indexed keywords

AMINO ACID TRANSPORTER; ANTISENSE OLIGONUCLEOTIDE; ARGININE; COMPLEMENTARY RNA; DOPA; DOPAMINE; PHENYLALANINE; PHENYLALANINE DERIVATIVE; POLYADENYLATED RNA; POLYADENYLIC ACID; PROTEIN LAT2; PROTEIN RBAT; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; FEMALE; GLOMERULUS FILTRATION; HOMEOSTASIS; KIDNEY CORTEX; KIDNEY PROXIMAL TUBULE; MICHAELIS MENTEN KINETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PRIORITY JOURNAL; XENOPUS LAEVIS;

EID: 2942670727     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00237.2003     Document Type: Article

References (38)

1. Antonipillai I, Broers MI, and Land D. Evidence that specific dopamine-1 receptor activation is involved in dopamine-induced renin release. Hypertension 13: 463-468, 1989.
2. Asico LD, Ladines C, Fuchs S, Accili D, Carey RM, Semeraro C, Pocchiari F, Felder RA, Eisner GM, and Jose PA. Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest 102: 493-498, 1998.
3. Baines AD and Chan W. Production of urine free dopamine from DOPA: a micropuncture study. Life Sci 26: 253-259, 1980.
4. Chan YL. Cellular mechanism of renal tubular transport of L-DOPA and its derivatives inn the rat: microperfusion studies. J Pharmacol Exp Ther 199: 17-24, 1976.
5. Felder CC, McKelvey AM, Gitler MS, Eisner GM, and Jose PA. Dopamine receptor subtypes in renal brush border and basolateral membranes. Kidney Int 36: 183-193, 1989.
6. Gill JR, Grossman E, and Goldstein DS. High urinary dopa and low urinary dopamine to dopa ratio in salt-sensitive hypertension. Hypertension 18: 614-621, 1991.
7. Gitomer WL, Reed BY, Ruml LA, Sakhaee K, and Pak CYC. Mutations in the genomic deoxyribonucleic acid for SLC3A1 in patients with cystinuria. J Clin Endocrinol Metab 83: 3688-3694, 1998.
8. Goldstein DS, Stull R, Eisenhofer G, and Gill JR. Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans. Clin Sci (Colch) 76: 517-522, 1989.
9. Gomes P, Serrao MP, Viera-Coelho MA, and Soares-da-Silva P. Opossum kidney cells take up L-DOPA through an organic cation potential-dependent and proton-independent transporter. Cell Biol Int 21: 249-255, 1997.
10. o.+, exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines. J Membr Biol 186: 63-80, 2002.
11. Gonska T, Hirsh JR, and Schlatter E. Amino acid transport in the renal proximal tubule. Amino Acids (Vienna) 19: 395-407, 2000.
12. Haberle DA and Konigbauer B. Inhibition of tubuloglomerular feedback by the D1 agonist fenoldopam in chronically salt-loaded rats. J Physiol 441: 23-24, 1991.
13. Hagege J and Richet G. Proximal tubule dopamine histofluorescence in renal slices incubated with L-DOPA. Kidney Int 27: 3-8, 1985.
14. Hayashi M, Yamaji Y, Kitajima W, and Saruta T. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol Renal Fluid Electrolyte Physiol 258: F28-F33, 1990.
15. Jaeger P, Portmann L, Saunders A, Rosenberg LE, and Their SO. Anticystinuric effects of glutamine and of dietary sodium restriction. N Engl J Med 315: 1120-1123, 1986.
16. Jose P, Eisner GM, Drago J, Carey RM, and Felder RA. Dopamine receptor signaling defects in spontaneous hypertension. Am J Hypertens 9: 400-405, 1996.
17. Kim DK, Kanai Y, Matsuo H, Kim JY, Chairoungdua A, Kobayashi Y, Enomoto A, Cha S, Goya T, and Endou H. The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics 79: 95-103, 2002.
18. Krishna GG, Danovitch GM, Beck FW, and Sowers JR. Dopaminergic mediation of the natriuretic response to volume expansion. J Lab Clin Med 105: 214-218, 1985.
19. Kuchel O and Shigetomi S. Defective dopamine generation from dihydroxyphenyl-alanine in stable essential hypertensive patients. Hypertension 19: 634-638, 1992.
20. McDonald RH, Goldberg LI, and McNay JL. Effect of dopamine in man: augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Invest 43: 1116-1124, 1964.
21. Oates NS, Ball SG, Perkins CM, and Lee MR. Plasma and urine dopamine in man given sodium chloride in the diet. Clin Sci (Colch) 56: 261-264, 1979.
22. Olsen NV, Hansen JM, Ladefoged SD, Fogh-Andersen N, and Leyssac PP. Renal tubular reabsorption of sodium and water during infusion of low dose dopamine in normal man. Clin Sci (Colch) 78: 503-507, 1990.
23. Peces R, Sanchez L, Gorostidi M, and Alvarez J. Effects of variation in sodium intake on cystinuria. Nephron 57: 421-423, 1991.
24. Rossier G, Meier C, Bauch C, Summa V, Sordat B, Verrey F, and Kuhn LC. LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of the kidney and intestine. J Biol Chem 274: 34948-34954, 1999.
25. Schnermann J, Todd KM, and Briggs JP. Effect of dopamine on the tubuloglomerular feedback mechanism. Am J Physiol Renal Fluid Electrolyte Physiol 258: F790-F798, 1990.
26. Schoors DF and Dupont AG. Increased dopamine-induced nephrogenous cAMP formation in hypertension. Am J Hypertens 4: 494-499, 1991.
27. +-ATPase. Am J Physiol Renal Fluid Electrolyte Physiol 258: F52-F60, 1990.
28. Shikuma R, Yoshimura M, Kambra S, Yamazaki R, Takahashi H, Takeda K, and Ijichi H. Dopaminergic modulation of salt-sensitivity in patients with essential hypertension. Life Sci 38: 915-921, 1986.
29. Soares-da-Silva P. Actin cytoskeleton, tubular sodium and the renal synthesis of dopamine. Biochem Pharmacol 3: 1883-1886, 1992.
30. Soares-da-Silva P. Enhanced protein kinase C mediated inhibition of renal dopamine synthesis during high sodium intake. Biochem Pharmacol 45: 1791-1800, 1993.
31. Soares-da-Silva P. Source and handling of renal dopamine: its physiological importance. News Physiol Sci 9: 128-134, 1994.
32. Soares-da-Silva P, Fernandes MH, and Pinto-do-O PC. Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules. Br J Pharmacol 112: 611-615, 1994.
33. Soares-da-Silva P, Pestana M, and Fernandez MH. Involvement of tubular sodium in the formation of dopamine in the human renal cortex. J Am Soc Nephrol 3: 1591-1599, 1993.
34. Soares-da-Silva P, Serrao MP, and Viera-Coelho MA. Apical and basolateral uptake and intracellular fate of dopamine precursor L-dopa in LLC-PK1 cells. Am J Physiol Renal Physiol 274: F243-F251, 1998.
35. + transport and water permeability in rat CCD via a D4-like receptor. Am J Physiol Renal Fluid Electrolyte Physiol 271: F391-F400, 1996.
36. Takezako T, Noda K, Tsuji E, Koga M, Sasaguri M, and Arakawa K. Adenosine activates aromatic L-amino acid decarboxylase activity in the kidney and increases dopamine. J Am Soc Nephrol 12: 29-36, 2001.
37. Verrey F, Jack DL, Paulsen IT, Saier MH, and Pfeiffer R Jr. New glycoprotein-associated amino acid transporters. J Membr Biol 172: 181-192, 1999.
38. Wolfovitz E, Grossman E, Folio CJ, Keiser HR, and Kopin IJ. Derivation of urinary dopamine from plasma dihydroxyphenylalanine in humans. Clin Sci (Colch) 84: 549-557, 1993.